-
Benchmark Reiterates Speculative Buy Rating on Milestone Scientific (MLSS) Amid CompuFlo Progress
-
Milestone Scientific (MLSS) Misses Q2 EPS by 1c
-
Milestone Scientific begins sales of epidural system at New Jersey clinic
-
Benchmark Reiterates Speculative Buy Rating on Milestone Scientific (MLSS)
-
Milestone Scientific (MLSS) Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
-
Milestone Scientific (MLSS) Reports In-Line Q1 EPS
-
Benchmark Reiterates Buy Rating on Milestone Scientific (MLSS)
-
Milestone Scientific (MLSS) introduces CompuFlo epidural system
-
Milestone Scientific (MLSS) Announces Commercial Rollout of CompuFlo Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
-
Milestone Scientific (MLSS) Misses Q3 EPS by 1c
-
Milestone Scientific (MLSS) Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
-
Milestone Scientific (MLSS) Announces Commercial Rollout of CompuFlo Epidural System
-
Milestone Scientific (MLSS) Tops Q2 EPS by 1c
-
Milestone Scientific (MLSS) Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
-
Milestone Scientific (MLSS) Secures Key Patent Approvals in the U.S. and Europe
-
Milestone Scientific (MLSS) Announces Favorable Medicare Pricing for its CompuFlo Epidural System
-
Milestone Scientific (MLSS) Receives Regulatory Approval to Market CompuFlo Epidural System in Brazil

